-+ 0.00%
-+ 0.00%
-+ 0.00%

Optimi Health completes third commercial shipment of psilocybin capsules to Australia

PUBT·06/29/2026 13:00:55
Listen to the news
Optimi Health completes third commercial shipment of psilocybin capsules to Australia
  • Optimi Health completed an export order of 1,000 finished 5 mg psilocybin capsules to Australia for treatment-resistant depression patients.
  • Shipment marked its third commercial delivery since the product launched in September 2025.
  • Product was manufactured at its Princeton, British Columbia GMP facility, then shipped under Health Canada export authorization.
  • Company cited recurring Australian orders as a contributor to commercial revenue.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Optimi Health Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-286955), on June 29, 2026, and is solely responsible for the information contained therein.